{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:59:36Z","timestamp":1778579976294,"version":"3.51.4"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T00:00:00Z","timestamp":1234483200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0004445","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T19:18:21Z","timestamp":1234466301000},"page":"e4445","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["Late HIV Diagnosis and Determinants of Progression to AIDS or Death after HIV Diagnosis among Injection Drug Users, 33 US States, 1996\u20132004"],"prefix":"10.1371","volume":"4","author":[{"given":"Anna","family":"Grigoryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Irene","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonji","family":"Durant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2009,2,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.285.10.1308","article-title":"Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984\u20131997.","volume":"285","author":"LM Lee","year":"2001","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.","volume":"135","author":"EL Murphy","year":"2001","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/QAD.0b013e32802ef30c","article-title":"Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.","volume":"21(6)","author":"VD Lima","year":"2007","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-138-8-200304150-00007","article-title":"Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4<sup>+<\/sup> cell strata.","volume":"138","author":"JF Palella","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/00002030-200109070-00015","article-title":"Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.","volume":"15","author":"DD Celentano","year":"2001","journal-title":"AIDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00126334-200501010-00017","article-title":"Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.","volume":"38","author":"KA Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurpub\/13.4.347","article-title":"Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level.","volume":"13","author":"LC Van Asten","year":"2003","journal-title":"Eur J Public Health"},{"key":"ref8","first-page":"158","article-title":"\u201cInformed altruism\u201d and \u201cpartner restriction\u201d in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990\u20132001.","volume":"35(2)","author":"DC Des Jarlais","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2105\/AJPH.89.9.1397","article-title":"Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985\u20131997.","volume":"89","author":"LS Weinhardt","year":"1999","journal-title":"Am J Public Health"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.annepidem.2006.01.009","article-title":"Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001.","volume":"16","author":"IH Hall","year":"2006","journal-title":"Ann Epidemiol"},{"key":"ref11","article-title":"HIV\/AIDS surveillance report, 2005, Vol. 17. Rev. ed","year":"2007"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/03610928808829621","article-title":"A generalized Kaplan-Meier estimator for heterogeneous populations.","volume":"17","author":"D Amato","year":"1988","journal-title":"Commun Stat Theory Methods"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies.","volume":"360","author":"M Egger","year":"2002","journal-title":"Lancet"},{"key":"ref14","first-page":"656","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.","volume":"169(7)","author":"E Wood","year":"2003","journal-title":"CMAJ"},{"key":"ref15","first-page":"389","article-title":"Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States.","volume":"35(2)","author":"R Andersen","year":"2000","journal-title":"Health Serv Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00126334-199912010-00008","article-title":"A comparison of exposure groups in the EuroSIDA Study: Starting highly active antiretroviral therapy (HAART), response to HAART, and survival.","volume":"22(4)","author":"A Mocroft","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref17","first-page":"1267","article-title":"Determinants of survival following HIV-1 seroconversion after the introduction of HAART.","volume":"362(9392)","author":"K Porter","year":"2003","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/jech.2003.010066","article-title":"Impact of injecting drug use on the interruption of antiretroviral therapies.","volume":"58","author":"R Muga","year":"2004","journal-title":"J Epidemiol Commun Health"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00002030-200403050-00013","article-title":"Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study.","volume":"18","author":"CA Kleeberger","year":"2004","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.280.6.547","article-title":"Barriers to use of free antiretroviral therapy in injection drug users.","volume":"280(6)","author":"SA Strathdee","year":"1998","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/339447","article-title":"Directly observed therapy for the treatment of people with human immunodeficiency virus infection: A work in progress.","volume":"34(7)","author":"JA Mitty","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/432883","article-title":"Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.","volume":"41","author":"R Kohli","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00126334-200210010-00011","article-title":"HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing.","volume":"31","author":"SE Kellerman","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref24","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.","volume":"55(RR-14)","year":"2006","journal-title":"MMWR"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00002030-199807000-00016","article-title":"Determinants of delayed diagnosis of HIV infection in France, 1993\u20131995.","volume":"12","author":"E Couturier","year":"1998","journal-title":"AIDS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00002030-200106150-00006","article-title":"Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy.","volume":"15","author":"K Poundstone","year":"2001","journal-title":"AIDS"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2165\/00002512-200219090-00003","article-title":"HIV disease and advanced age: An increasing therapeutic challenge.","volume":"19","author":"R Manfredi","year":"2002","journal-title":"Drugs Aging"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","article-title":"Rates of disease progression by baseline of CD4 cell count and viral load after initiating triple-drug therapy.","volume":"286","author":"RS Hogg","year":"2001","journal-title":"JAMA"},{"key":"ref29","article-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents.","year":"2008"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0004445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:51:24Z","timestamp":1540219884000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0004445"}},"subtitle":[],"editor":[{"given":"Howard E.","family":"Gendelman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,2,13]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0004445","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,13]]}}}